In rheumatic cohorts, serum Gal-3 levels more than 12.5 ng/mL are predictive of myocardial fibrosis on cardiac magnetic resonance imaging (CMR) and hospitalization for heart failure [22]. The gene discussed is LGALS3; the disease is Myocardial fibrosis.